Short answer
Evidence is limited. A few small trials report modest pain relief from cannabis-based medicines in people with arthritis. No cannabis or CBD product holds FDA approval for arthritis. Most data comes from animal models. Animal results do not prove benefit in people.
What the trials show
Rheumatoid arthritis
A 2006 trial published in Rheumatology tested Sativex, an oral spray that contains THC and CBD, in 58 adults with rheumatoid arthritis. The study ran 5 weeks. Patients on Sativex reported less pain on movement and lower scores on a pain rating scale than the placebo group. The trial was small and short. Sativex is not approved in the US.
medical cannabis for arthritis dosage
Osteoarthritis
Human trial data for osteoarthritis is thin. Most reports come from surveys and case series. In those reports some patients describe less pain and better sleep. Survey data cannot separate a drug effect from placebo, expectation, or other treatments taken at the same time. Rat studies of knee osteoarthritis show less joint swelling and lower pain markers after CBD. Rat joints are not human joints.
Medical Marijuana for Arthritis: Options, Dosing, and Evidence
Topical CBD
Topical CBD has been tested in a small number of hand arthritis cases. Results are mixed and sample sizes are small. No standard dose exists. Skin absorption differs by formulation.
medical cannabis for arthritis dosage
How cannabinoids act on joints
THC binds CB1 receptors, which sit in the brain and nervous system. CBD binds CB1 and CB2 with low affinity. CB2 receptors sit on immune cells. Inflammation in arthritis involves those same immune cells. The mechanism is plausible. A mechanism is not proof of clinical effect.
US regulatory status
The FDA has not approved cannabis for any arthritis indication. Epidiolex, a purified CBD drug, is approved for three rare seizure disorders. Hemp-derived CBD at 0.3 percent THC or less is legal under federal law. State law governs THC cannabis. Labels on hemp CBD products are not always accurate. Independent testing has found gaps between stated and actual cannabinoid content.
Risks and interactions
- CBD inhibits the CYP2C19 and CYP3A4 enzymes. It can raise blood levels of some drugs, including certain blood thinners and seizure medicines.
- High-dose CBD caused liver enzyme elevations in trials. The Epidiolex label requires liver monitoring.
- THC can cause dizziness, dry mouth, poor coordination, and cognitive effects. It carries dependence risk.
- Smoked cannabis irritates the airways.
- Mixing cannabis with opioids or sedatives adds sedation risk.
Arthritis by the numbers
About 53 million US adults have diagnosed arthritis, per CDC data. Standard care includes physical activity, weight management, NSAIDs, corticosteroids, and disease-modifying drugs for inflammatory types. Cannabis is not a substitute for those treatments.
Questions for a clinician
- Will CBD interact with my current prescriptions?
- Is my arthritis inflammatory or mechanical? The answer changes the treatment plan.
- What dose and product form have been studied?
- How will we measure whether it works?